One of the key takeaways from the global pandemic for communities around the world is perhaps the importance of vaccines in preventing serious illness and death from infectious diseases. While vaccine hesitancy continues to be an issue, figures have shown that mortality rates among people who have received COVID-19 vaccines are significantly lower than those who are unvaccinated.
In this session, four of today's leading infectious disease and public health experts discuss current pressing public health issues and how vaccines provide a solution to addressing them.
Moderated by Dr Alain Bouckenooghe, Head of R&D at Hilleman Laboratories, this session features:
Prof Gordon Dougan, Director, Infectious Disease, Wellcome Trust
The Wellcome Trust is committed to protecting the world against different types of infectious disease, and the threat of disease escalation now and in the future. Professor Dougan outlines how Wellcome Trust plans to tackle urgent health challenges by combatting infectious diseases, especially in low- and middle-income countries.
Prof Paul Tambyah, Senior Consultant & Professor, Department of Medicine, National University of Singapore
Drawn from his experience as an infectious disease physician of many years, Professor Tambyah shares his perspective on the evolution of vaccines and vaccine development over the past decades, and the impact on physicians, patients and population health.
Prof Rino Rappuoli, Head of Vaccine R&D, GSK Vaccines
In this invited lecture, Professor Rappuoli takes us through the fascinating journey of vaccines research and development, beginning with the pages of the notebook of Louis Pasteur circa 1885, to today’s digital world of making vaccines.
Prof Gagandeep Kang, Director, Wellcome Trust Research Laboratory
Public health is a complex topic, invoking elements of governance, policy, manpower and resources. In this distinguished lecture, Professor Kang shares the practical approaches for interventions and improvements in public health, focusing on monitoring and surveillance, and the importance of evaluating the impact of interventions.
